Singapore markets closed

Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.6500+0.1700 (+4.89%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-18,433
-20,132
-18,107
-4,372
-5,339
Depreciation & amortisation
2,682
8,747
2,706
2,579
2,676
Deferred income taxes
29
29
116
610
31
Stock-based compensation
962
1,435
910
997
1,331
Change in working capital
-1,866
-15,801
2,689
-1,349
-1,390
Accounts receivable
-3,930
-17,159
-863
-2,206
2,631
Inventory
325
-260
1,010
-19
-1,259
Accounts payable
1,753
-1,875
1,468
1,485
106
Other working capital
-14,699
-89,793
-10,230
-3,845
-2,813
Other non-cash items
1,095
1,023
1,153
-9
972
Net cash provided by operating activities
-14,407
-14,261
-9,975
-3,224
-2,193
Cash flows from investing activities
Investments in property, plant and equipment
-292
-75,532
-255
-621
-620
Net cash used for investing activities
-292
-75,532
-255
-621
-620
Cash flows from financing activities
Debt repayment
-225
-485
-289
-221
-426
Common stock issued
82
2,404
85
10,084
49
Common stock repurchased
-1,252
-1,252
0
-
-
Other financing activities
-5,285
-5,285
-113
-82
-19
Net cash used provided by (used for) financing activities
-128
96,499
-302
9,823
3,882
Net change in cash
-16,016
6,786
-11,240
5,302
1,783
Cash at beginning of period
21,558
5,304
16,544
11,242
9,459
Cash at end of period
6,731
12,090
5,304
16,544
11,242
Free cash flow
Operating cash flow
-14,407
-14,261
-9,975
-3,224
-2,193
Capital expenditure
-292
-75,532
-255
-621
-620
Free cash flow
-14,699
-89,793
-10,230
-3,845
-2,813